The drugmaker Ely Lilly ( LLY -4.93%) has had a very successful run over the long run. Shares currently trade around $818 and are up 20,030% over the past 40 years. The stock has also performed well ...
In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...
The headline trial results will be closely monitored by pharmaceutical industry experts. Shares in Novo Nordisk, which ...
Prediction: 3 Stocks That'll Be Worth More Than Tesla 10 Years From Now was originally published by The Motley Fool When ...
But for diabetes and obesity drugs like Ozempic and Zepbound, known as GLP-1s, cheaper copycats emerged almost ...
Medpage Today on MSN22h
Tirzepatide Officially Puts GLP-1 Meds on the Map for Obesity-Related Heart FailureCHICAGO -- A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and ...
New federal reports value a massive investment portfolio of stocks, bonds and mutual funds managed on behalf of The Church of ...
WTAJ Altoona on MSN3h
‘Breakfast with Santa’ across Central PennsylvaniaIt’s the most wonderful time of the year, as they say, and with the holidays comes Breakfast with Santa. Many volunteer fire ...
Equity markets have performed well in 2024, but their showing pales next to that of Viking Therapeutics (NASDAQ: VKTX), a mid ...
(Reuters) -Shares in European vaccine makers fell on Friday after U.S. President-elect Donald Trump picked Robert F. Kennedy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback